CLINICAL_TRIALS
research
· 2014-03-03
Clinical Trial Update: Pilot Evaluation Of CORACTO® (THE PILOT-SECRET TRIAL) [Phase 3]
Summary
Phase 3 pilot trial evaluating CORACTO for coronary artery disease; status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alvimedica | Conditions: Coronary Artery Disease | Phase 3 | Status: UNKNOWN